These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Ong KC; Kor AC; Chong WF; Earnest A; Wang YT Am J Respir Crit Care Med; 2004 May; 169(9):1028-33. PubMed ID: 14977622 [TBL] [Abstract][Full Text] [Related]
63. A dose response study of oxitropium bromide in chronic bronchitis. Peel ET; Anderson G Thorax; 1984 Jun; 39(6):453-6. PubMed ID: 6463915 [TBL] [Abstract][Full Text] [Related]
64. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer. Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292 [TBL] [Abstract][Full Text] [Related]
65. [Physical exercise tolerance in chronic obstructive emphysematous bronchitis and coronary heart disease under antiobstructive therapy]. Hürter T; Ochs JG; Schmitz E; Hartmann M; Alex C; Sigmund M; Hanrath P Dtsch Med Wochenschr; 1992 Oct; 117(43):1623-9. PubMed ID: 1425260 [TBL] [Abstract][Full Text] [Related]
66. The relationship between maximal expiratory flow and increases of maximal exercise capacity with exercise training. Babb TG; Long KA; Rodarte JR Am J Respir Crit Care Med; 1997 Jul; 156(1):116-21. PubMed ID: 9230734 [TBL] [Abstract][Full Text] [Related]
67. Effects of inhalation or incubation of oxitropium bromide on diaphragm muscle contractility in mice. Shindoh C; Shishido R; Sasaki K; Miura M Allergol Int; 2011 Sep; 60(3):365-72. PubMed ID: 21593578 [TBL] [Abstract][Full Text] [Related]
68. The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. Lowry R; Wood A; Higenbottam T Br J Clin Pharmacol; 1994 Feb; 37(2):187-91. PubMed ID: 8186064 [TBL] [Abstract][Full Text] [Related]
69. Fenoterol powder inhaler technique in children: influence of inspiratory flow rate and breath-holding. Pedersen S; Steffensen G Eur J Respir Dis; 1986 Mar; 68(3):207-14. PubMed ID: 3699121 [TBL] [Abstract][Full Text] [Related]
70. [Quantitative assessment of dyspnea by introducing new indices based on the Borg scale during exercise test and the correlation with parameters of pulmonary functions at rest]. Suruda T; Fukuchi Y; Matsuse T; Nagase T; Teramoto S; Yamaoka M; Hirose T; Orimo H Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1471-7. PubMed ID: 2290232 [TBL] [Abstract][Full Text] [Related]
71. Bronchospasmolytic effect of oxitropium bromide following powder inhalation in anaesthetized dogs. Traunecker W Arzneimittelforschung; 1988 Nov; 38(11):1623-4. PubMed ID: 3214446 [TBL] [Abstract][Full Text] [Related]
72. [Effect of a new anticholinergic bronchodilator aerosol, 8-isopropylscopolamine bromide, on chronic obstructive pulmonary disease]. Huang ZB Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Feb; 7(1):24-7. PubMed ID: 6147238 [No Abstract] [Full Text] [Related]
73. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation. Morrison JF; Jones PC; Muers MF Eur Respir J; 1992 Apr; 5(4):424-9. PubMed ID: 1532940 [TBL] [Abstract][Full Text] [Related]
74. Study of the bronchodilating effect of three doses of nebulized oxitropium bromide in asthmatic preschool children using the forced oscillation technique. Pauwels JH; Desager KN; Creten WL; Van der Veken J; Van Bever HP Eur J Pediatr; 1997 Apr; 156(4):329-32. PubMed ID: 9128822 [TBL] [Abstract][Full Text] [Related]
75. Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study. Centanni S; Santus P; Casanova F; Carlucci P; Boveri B; Castagna F; Di Marco F; Cazzola M Respir Med; 2002 Mar; 96(3):137-41. PubMed ID: 11905547 [TBL] [Abstract][Full Text] [Related]
76. [Comparison of beta-2-agonist and beclomethasone effects on potassium levels, heart action and pulmonary ventilation parameters in patients with chronic asthmatic bronchitis]. Burak W; Grzeszczak W; Dabrowski G Wiad Lek; 1993 Mar; 46(5-6):173-7. PubMed ID: 8249391 [TBL] [Abstract][Full Text] [Related]
77. Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise tolerance in hypoxemic patients with chronic obstructive pulmonary disease. Ribeiro SA; Jardim JR; Romaldini H; Novo NF; Nery LE Braz J Med Biol Res; 1995 Aug; 28(8):859-67. PubMed ID: 8555987 [TBL] [Abstract][Full Text] [Related]
78. [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)]. Kaik G; Kaik B; Laggner A Wien Med Wochenschr; 1980 Jun; 130(11):385-93. PubMed ID: 6449783 [TBL] [Abstract][Full Text] [Related]
79. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease. Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769 [TBL] [Abstract][Full Text] [Related]
80. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. O'Donnell DE; D'Arsigny C; Webb KA Am J Respir Crit Care Med; 2001 Mar; 163(4):892-8. PubMed ID: 11282762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]